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Abstract
Background. Cystic pancreatic neoplasms (CPNs) present a unique challenge in preoperative diagnosis. We investigated the
accuracy of diagnostic methods for CPN. Material and methods. This retrospective cases series includes 70 patients who
underwent surgery at a university hospital for presumed CPNs between 1997 and 2003, and for whom a definitive diagnosis
was established. Variables examined included symptoms, preoperative work-up (including endoscopic retrograde
cholangiopancreatography (ERCP) in 22 cases and endoscopic ultrasound (EUS) in 12), and operative and pathological
findings. Preoperative computed tomography (CT) and magnetic resonance imaging (MRI) scans (n50 patients; CT
48; MRI13) were independently reviewed by two blinded GI radiologists. Results. The final histopathologic diagnoses
were mucinous cystic neoplasm (n13), mucinous cystadenocarcinoma (10), serous cystadenoma (11), IPMN (14),
simple cyst (3), cystic neuroendocrine tumor (5), pseudocyst (4), and other (10). Overall, 25 of 70 were malignant (37%),
21 premalignant (30%), and 24 benign (34%). The attending surgeon’s preoperative diagnosis was correct in 31% of cases,
incorrect in 29%, non-specific ‘‘cystic tumor’’ in 27%, and ‘‘pseuodcyst vs. neoplasm’’ in 11%. Eight had been previously
managed as pseudocysts, and 3 pseudocysts were excised as presumed CPN. In review of the CT and MRI, a multivariate
analysis of the morphologic features did not identify predictors of specific pathologic diagnoses. Both radiologists were
accurate with their preferred (no. 1) diagnosis in B50% of cases. MRI demonstrated no additional utility beyond CT.
Conclusions. The diagnosis of CPN remains challenging. Cross-sectional imaging methods do not reliably give an accurate
preoperative diagnosis. Surgeons should continue to err on the side of resection.
Key Words: Computed tomography (CT), cystadenocarcinoma, cystadenoma, cystic, magnetic resonance (MR), mucinous,
neoplasm, pancreas, serous
Introduction
Cystic pancreatic neoplasms (CPNs), whether con-
genital, inflammatory, or neoplastic, are diagnostically
challenging. They account for 1015% of cystic
lesions of the pancreas and 5% of primary pancreatic
neoplasms [1,2]. Many reports show that the pre-
valence is rising. They are commonly found inciden-
tally on computed tomography (CT) scans [3] and
represent a growing indication for resection at referral
centers [1,4]. The diagnosis relies principally on CT
and magnetic resonance imaging (MRI). Efforts to
differentiate among these tumors from imaging tests
have met with mixed success [5,6]. Although certain
features have been emphasized as being classic for
specific kinds of CPN, the diagnostic power of these
features has not been subjected to objective analysis.
Endoscopic ultrasound (EUS) is now being used to
investigate cystic pancreatic lesions, particularly as a
means of cyst aspiration [7]. How analysis of cyst fluid
will strengthen the diagnostic algorithm remains
unsettled [8]. The aim of this study was to investigate
the preoperative diagnostic evaluation of cystic pan-
creatic lesions in determining how imaging and
clinical factors should guide management.
Methods
Using the University of California San Francisco
(UCSF) Department of Pathology database, we retro-
spectively identified 70 patients who between 1997
and 2003 underwent surgical exploration for pre-
sumed CPNs, or who were ultimately found to have a
CPN at operation (e.g. the preoperative diagnosis was
pseudocyst but the lesion proved to be a cystic
neoplasm). The histopathology of all lesions was
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established by resection (n60) or surgical biopsy
(n10). Patients were excluded who had transcuta-
neous or endoscopic fine-needle aspiration (FNA)
alone (without subsequent surgical exploration) or if
the pathology results did not give a specific diagnosis.
A pathologic diagnosis of malignancy was based on
invasion of the pancreatic parenchyma or metastases.
Mucinous cystic neoplasms and intraductal papillary
mucinous tumors (IPMTs) that did not have con-
clusive evidence of carcinoma were considered to be
premalignant [9,10]. Increasingly, pathologists use
the term ‘mucinous cystic neoplasm’ for all mucinous
tumors in order to emphasize the overlap in malignant
potential of these tumors. Alternatively, they are
divided into three categories: adenoma, borderline,
and adenocarcinoma. We prefer the standard classifi-
cation, dividing mucinous tumors into just cystade-
noma and cystadenocarcinoma with few exceptions,
which more accurately reflects how the patients are
managed clinically and their outcome [11]. Though
there are instances in which patients with completely
resected mucinous cystadenomas have developed
metastatic disease, these are rare [9].
The preoperative data included age at diagnosis,
presenting symptoms, and the results of diagnostic
tests. Details of the operations were obtained from the
operative notes and pathology reports, including the
extent of excision, perioperative course, complica-
tions, and outcome.
Preoperative CT and MRI scans that were available
for review (n50 patients; CT48; MRI13) and
scans from patients with pathologically proven pseu-
docysts (CT5, MRI5) were analyzed. Fourteen
of these scans had been performed at other institu-
tions. Two abdominal radiologists, blinded to all
demographic and clinical data, independently re-
viewed the CT and MRI images at separate sessions.
Each reader recorded 22 separate morphologic tumor
characteristics, the probability of specific diagnoses,
and the overall likelihood of malignancy. Multivariate
analysis (manual stepwise regression using backward
elimination) was used to investigate morphologic
characteristics as predictors of malignancy and speci-
fic diagnoses (using ANOVA for continuous variables
and the chi-squared test for discrete characteristics).
The statistical analyses were performed using the
software packages Stata Version 8.0 (Stata Corp,
College Station, Tx., USA) and StatXact (Cytel
Software, Cambridge, Mass., USA).
This study was reviewed and approved by the
UCSF Committee on Human Research.
Results
Seventy patients underwent laparotomies for pre-
sumed CPN or were found to have a CPN at an
operation where the preoperative diagnosis was some-
thing other than CPN (e.g. pseudocyst). There were
48 women and 22 men and the mean age was 60
(916) years.
Seventy-nine operations were performed: distal
pancreatectomy (open or laparoscopic) (n28),
Whipple pancreaticoduodenectomy (21), biopsies
with or without palliative bypass (10), enucleation
(6), total or subtotal pancreatectomy (5), and cysten-
terostomy (7). Six patients had more than one
operation. Five patients with cystic neoplasms initially
had cystenterostomies (twice in one patient) for
presumed pseudocysts before the lesion was resected.
A patient who had previously undergone a distal
pancreatectomy for a cystic neoplasm underwent a
Whipple completion pancreatectomy for a presumed
recurrence in the head of the gland. On pathologic
examination, the second lesion proved to be a
pseudocyst.
The final pathologic diagnoses for all patients are
listed in Table I. Overall, 25 (36%) of 70 were
malignant, 21 (30%) were premalignant, and 24
(34%) were benign. Fourteen (19%) were discovered
incidentally in asymptomatic patients; of these, 3
(21%) were malignant, 6 (43%) were premalignant,
and 5 (36%) were benign.
Laboratory values contributed little to the preo-
perative diagnosis. Hyperamylasemia (2 the
upper limit of normal) was present in three patients:
one had an islet cell tumor and two had mucinous
cystic neoplasms. Four patients had elevated bilirubin
levels. Their diagnoses were as follows: mucinous
cystadenoma of the pancreatic head, IPMN with
adenocarcinoma, mucin-producing ductal adenocar-
cinoma, chronic sclerosing pancreatitis with PanIN-3.
No laboratory tests were predictive of any individual
pathologic lesion or the presence of carcinoma.
Preoperative evaluation included CT and/or MRI
scans in all patients and endoscopy in 34. Endoscopic
retrograde cholangiopancreatography (ERCP) per-
formed in 22 patients demonstrated mucin at the
ampulla and dilatation of the pancreatic duct in all of
the 6 patients with IPMT who underwent ERCP. In
two cases, mucinous cystic neoplasms were found to
communicate with the pancreatic duct, and this
finding was interpreted erroneously by the endosco-
pist as being diagnostic of pancreatic pseudocyst. The
other studies were normal (4 patients), technically
unsuccessful (2 patients), demonstrated non-specific
irregularity or ectasia of the pancreatic duct (4 pa-
tients), or showed dilatation of the bile duct with a
normal pancreatic duct (4 patients).
Twelve patients underwent EUS. The correct
diagnosis was suggested in two of these cases by their
imaging features and in four by cyst aspiration (for
cytology in one and carcinoembryonic antigen (CEA)
in three). EUS proved non-diagnostic in four cases,
and the interpretation of the findings was incorrect in
two other cases.
All patients had preoperative cross-sectional ima-
ging, including CT scans in 69 and MRI in 13. The
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preoperative radiology reports were available for 47 of
the scans and, among these, the radiologist’s diagnosis
was correct in 10 (21%) and incorrect in 15 (32%). In
18 (38%) reports the final pathologic diagnosis was
within the radiologist’s differential diagnosis, while no
diagnosis was offered in 4 (9%) cases.
CTand MRI images were available for re-review for
50 of the 70 patients (CT48; MRI13). Scans
from patients with pathologically proven pseudocysts
were included in the blinded analysis (CT5, MRI
5) as controls.
With respect to the readers’ descriptions of the
specific morphologic characteristics of each scan or
image, inter-observer agreement for continuous and
binary outcomes was good (Pearson’s correlation
coefficient: 0.730.90). Overall diagnostic accuracy
and likelihood of predicting malignancy were not
significantly different between the two readers (p
0.86 and 0.63, respectively; McNemar’s chi-squared
test).
Multivariate analysis was performed using a model
that included 22 separate variables (size, locularity,
lesion wall thickness, presence of solid nodules,
calcification, number of locules, septal thickness,
etc.; see Appendix I). Individual morphologic char-
acteristics proved to be poor predictors of malignancy
and of specific histopathologic diagnoses. Overall, the
heterogeneity among cystic lesions and significant
overlap in morphologic characteristics between the
different diseases made it impossible to identify
features that consistently predicted specific diagnoses
or reliably distinguished benign from malignant and
premalignant lesions.
Combining the CT and MRI data, Reader 1 was
correct in 46%, 61%, and 66% of cases with respect to
his number 1 diagnosis, top 2 diagnoses, and top 3
diagnoses, respectively. Reader 2’s accuracy was
comparable (43%, 64%, and 67%). The results of
CT and MRI diagnoses were of similar accuracy for
both readers (Table II). To investigate the possibility
that a subset of the lesions was causing diagnostic
confusion, we looked at those for which both readers
had the same first diagnosis, presumably the more
typical lesions. The readers’ first diagnosis was the
same in 28 (40%) of 70 scans, but these diagnoses
were correct in only 16 (57%) instances. In cases
where Reader 1 gave the correct diagnosis, Reader 2
agreed in only 53%; and if Reader 2 was correct,
Reader 1 agreed in 55%. We also determined the
accuracy of diagnosis when stratified according to
the readers’ certainty of their leading diagnosis. The
accuracy of their number 1 diagnosis improved to
just 55% and 48% (readers 1 and 2, respectively) as
the reader’s certainty increased to ]90%. This
questions the notion that certain typical features are
diagnostic.
It is the surgeon who synthesizes the clinical and
imaging findings to make the best possible diagnostic
Table I. Histopathologic diagnoses of patients preoperatively diagnosed with cystic pancreatic neoplasms.
Diagnosis All Premalignant Malignant
Mucinous cystadenoma 13 13
Mucinous cystadenocarcinoma 10 10
Intraductal papillary mucinous tumor 14 7 7
Serous cystadenoma 11
Neuroendocrine tumor 5 3
Pseudocyst 4
Simple cyst 3
Other 10 1 5
Cystic dilation due to duct obstruction
Mucin-producing ductal adenocarcinoma
Anaplastic pancreatic carcinoma
PanIN 3 (carcinoma-in-situ), chronic pancreatitis
Lymphoepithelial cyst
Lymphangioma
Solid pseudopapillary neoplasm
Cystic gastric duplication
Total 70 21 25
Table II. Accuracy of CT and MRI for Readers 1 and 2.
Reader 1 Reader 2
Correct re: CT MRI p-value CT MRI p-value
No. 1 diagnosis 44% 50% ns 40% 50% ns
Top 2 diagnoses 62% 62% ns 60% 78% ns
Top 3 diagnoses 65% 67% ns 62% 83% ns
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estimate. We investigated the accuracy of these pre-
operative diagnoses, which were available for 65 of the
70 patients. The surgeon’s preoperative diagnosis was
correct in 21 (32%) cases, incorrect in 20 (31%),
‘‘cystic tumor’’ (non-specific) in 16 (25%), and
‘‘neoplasm versus pseudocyst’’ in 8 (12%).
Eight patients were managed inappropriately be-
cause the preoperative diagnosis was incorrectly
thought to be pseudocyst (Table III). Five had
cystenterostomies before the correct diagnosis was
made and the cystic neoplasm was removed (one at
UCSF, 4 at community hospitals). Two patients were
managed unsuccessfully with pancreatic duct stents
for lengthy periods by gastroenterologists on the
assumption that they were treating pseudocysts. One
patient with abdominal pain and a cystic lesion in the
head of the pancreas was observed for three years.
After losing 35 pounds, an operation was performed
and unresectable mucinous cystadenocarcinoma was
found.
In four patients, lesions thought preoperatively to
be cystic tumors proved to be pseudocysts. Two
underwent distal pancreatectomies. In one case, the
lesion was recognized to be a pseudocyst during the
operation, and a cystgastrostomy was performed. One
patient underwent distal pancreatectomy for a solid
and papillary epithelial neoplasm. On a follow-up CT
scan he was found to have another cystic lesion in the
head of the gland, and a Whipple procedure was
performed for a presumed recurrence. The lesion was
a pseudocyst.
Discussion
In 1959, L. Henry Garland delivered a lecture at the
New York Academy of Medicine entitled ‘‘The
Problem of Observer Error’’, carefully outlining the
diagnostic errors found in every aspect of the clinical
evaluation of patients [12]. Garland’s research fo-
cused on the rate of error in the interpretation of
radiographs, as a result of both inter-observer varia-
bility and intra-observer variability (i.e. a single
radiologist has a fixed rate of inconsistency on re-
reading a set of films) [13]. Garland argued that a
measurable degree of human error was inherent to
these diagnostic tests due to the ‘‘human equation’’.
Now, nearly 50 years later, the clinical evaluation of
cystic pancreatic lesions appears to suffer from the
same limitations despite the improvement in the
diagnostic tools. Distinguishing CPNs from pseudo-
cysts and discriminating among the various CPNs is
important to appropriate management. The conse-
quences of mistaking a cystic tumor for a pseudocyst
can be serious [14,15]. Many asymptomatic lesions
are premalignant or malignant [16]. Given the mor-
bidity of pancreatic resections, however, it is impor-
tant to single out the lesions that may be managed
expectantly.
We included all patients who had surgery for a
suspected CPN or were ultimately found to have
cystic neoplasms, rather than confining the analysis to
proven CPN. Fourteen pathologic diagnoses were
included (Table I). When performed in this broad
context, the analysis more accurately shows the utility
of each study. A test that could distinguish a serous
from a mucinous cystadenoma is not sufficient, given
the myriad possibilities encountered in referral cen-
ters.
In this series, no laboratory studies helped predict
individual pathologic lesions or the presence of
carcinoma. Serum tumor markers (CEA, Ca 19-9,
Ca 125, etc.), though widely studied for pancreatic
ductal adenocarcinoma [17,18], have demonstrated
little value for the assessment of cystic neoplasms
[19]. Though hyperamylasemia suggests a diagnosis
of pancreatic pseudocyst, it does not rule out a CPN.
In this series, hyperamylasemia was seen in only three
patients, all who had neoplasms. Other authors have
similarly documented patients with cystic neoplasms
presenting with hyperamylasemia or a clinical history
of pancreatitis [2,9,20].
Endoscopy was used selectively. ERCP proved most
useful in patients with IPMN, demonstrating mucin
at the ampulla and diffuse dilatation of the pancreatic
duct [21]. Otherwise, ERCP contributed little. Nei-
ther the appearance of the duct, nor evidence that the
duct communicates with the cyst differentiated
among the possibilities [22]. Though pseudocysts
Table III. Patients misdiagnosed as pseudocysts.
n Age Initial management Final operation Final path
1 36 1. Cystgastrostomy
2. Cystjejunostomy
Distal pancreatectomy MCN
2 59 Cystjejunostomy Whipple Neuroendocrine tumor
3 56 Cystgastrostomy Distal pancreatectomy, partial
gastrectomy and colectomy
Anaplastic carcinoma
4 41 ERCP w/ stent into ‘cyst’ Ex-lap, biopsy (unresectable) Mucinous cyst-adenocarcinoma
5 46 Cystjejunostomy Distal pancreatectomy MCN
6 77 ‘‘Observation’’3 years Biopsy, double bypass (unresectable) Mucinous cyst-adenocarcinoma
7 45 ERCP w/ stent2 years Whipple MCN
8 44 Cystjejunostomy Distal pancreatectomy MCN
MCNmucinous cystadenoma; ex-lapexploratory laparotomy.
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often communicate with the duct, this finding also
occurs in many cases of mucinous cystic neoplasms
[2,14]. This was seen in two of our patients with
mucinous cystic neoplasms. The ERCP reports in
both cases listed pseudocyst as the principal diagnosis.
ERCP sampling of pancreatic secretions for cytology
and tumor markers (e.g. K-ras) has been reported,
but its validity is still unproved [23].
EUS offers two means of diagnosis of cystic
pancreatic lesions, i.e. morphologic imaging and
guidance for FNA [2430]. Twelve patients in this
series underwent EUS, which suggested the correct
diagnosis in two cases because of morphologic char-
acteristics and in four by FNA. Characterization of
morphology has shown little promise for differentiat-
ing cystic pancreatic lesions due to the overlap in
features [31] and to wide inter- and intra-observer
variability [39]. The sensitivity of cytology of pan-
creatic cyst aspirate is low [29,3234]. Cyst fluid
analysis  for tumor markers (CEA, CA 19-9, CA-
125), amylase, lipase, viscosity, and mucin  has been
investigated with the aim of finding one or a panel of
these tests that would differentiate among cystic
pancreatic lesions. CEA appears to be the most useful,
though the diagnostic cut-off varies [7,34,35]. Some
authors have reported considerable overlap in the
results of cyst fluid analysis among CPN and between
CPN and pseudocysts [36,37]. False negatives can
occur when the tumor communicates with the pan-
creatic duct and pancreatic juice dilutes cyst contents
[14]. Complications of FNA include the possibility of
spilling malignant cells into the peritoneum [38],
hemorrhage, and injury to adjacent organs. We
generally reserve FNA for lesions with a low risk of
cancer, a poor risk patient with an indeterminate
cystic mass in the head of the pancreas that would
require pancreatoduodenectomy, or a patient with a
probable mucinous tumor who desires additional
evidence prior to resection. There is some evidence
that EUS with FNA increases diagnostic accuracy
over cross-sectional imaging alone [39]. Although in
this series (through 2003) just 12 patients had EUS,
this technology is now used frequently.
Thus, the evaluation of cystic lesions relies heavily
on CT and MRI. Much of the available literature is
comprised of descriptions of the archetypal imaging
findings accompanying case reports [14,40,41]. Little
systematic analysis has been done to validate these
claims on the sensitivity or specificity of particular
findings or on the broader diagnostic accuracy CTand
MRI. Blinded analyses of CT scans from CPN have
given mixed results, and they typically only included
serous cystadenomas and mucinous cystic neoplasms
[5,6,42]. This does not mimic the diagnostic problem
of the clinician, who must choose among a wider
spectrum of possibilities.
Given that CT and MRI are the most useful
diagnostic tests, we investigated their accuracy in
our patients. The preoperative radiology reports
were unreliable: correct in 21%, within the differential
in 38%, incorrect in 32%, and no diagnosis in 9%.
Blind interpretations of the scans by a pair of highly
experienced abdominal radiologists were only slightly
better. The readers’ first diagnoses were accurate in
less than 50% of cases. Using a three-item differential
diagnosis, both radiologists were correct in two-thirds
of cases. MRI offered no additional utility over CT.
Even when the readers agreed on the first diagnosis,
and when the readers’ confidence was ]90%, the
accuracy improved to only 60%. This questions the
widely held belief that there are ‘‘classic’’ features that
possess great diagnostic weight.
We also looked for individual objective findings on
the imaging studies (size, calcification, etc.) or a
combination of findings that would prove more
accurate. There was little inter-observer variability in
the recording of morphologic features. However, the
heterogeneity among cystic lesions and overlap be-
tween diagnoses prevented reliable predictors from
emerging that consistently predicted the diagnosis or
distinguished benign from malignant lesions. Of note,
we did not find a clear size criterion that excluded
malignancy.
In this series, 2 of 15 (13%) unilocular, thin-walled
cysts 53 cm were malignant. This is somewhat
discrepant with the results of a recent study from
Massachusetts General Hospital in which 35 of 36
unilocular pancreatic cysts smaller than 3 cm were
benign [43]. The reason for this discordance is
unclear. In any case, the end-point of frank malig-
nancy is not sufficient for clinical management
because even though entities such as mucinous
cystadenomas are benign, they are considered to be
premalignant. Although criteria for selective observa-
tion are emerging [4446], these are hotly debated,
and many experts still recommend resection rather
than observation of suspected mucinous cystadeno-
mas of the pancreas for patients who are reasonable
candidates for surgery [47].
Though the radiographic studies standing alone
demonstrate significant shortcomings, the surgeon is
in a position to integrate the radiographic findings
with the clinical findings into a (presumably) more
informed assessment. The surgeon’s preoperative
diagnosis was correct in roughly one-third of cases,
incorrect in another third, and non-specific (e.g.
cystic tumor; neoplasm vs pseudocyst) in the remain-
der. This is similar to what others have reported
[2,4143]. For example, in a multicenter study by Le
Borgne and colleagues of 164 serous cystadenomas
and 222 mucinous tumors, the correct diagnosis was
made preoperatively in 20% of serous cystadenomas,
30% of mucinous cystadenomas, and 29% of muci-
nous cystadenocarcinomas [2].
The most important preoperative distinction is
between CPN and pseudocysts. The epithelial lining
of CPN may be partly denuded and misdiagnosed as a
pancreatic pseudocyst even when examined by frozen
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section [48], and the resulting error in management
may lead to recurrent or metastatic disease [14,15,
49]. Eight of our patients with CPN (12%) were
initially managed as pseudocysts. In two cases,
prolonged non-surgical management based on as-
sumptions that the lesions were benign allowed
cystadenocarcinoma to metastasize. Four out of five
patients who mistakenly had cystenterostomies had
benign tumors that were eventually cured by resec-
tion. The fifth eventually succumbed to metastatic
disease.
Pathologic confirmation of the diagnosis is neces-
sary to rigorously test the accuracy of each diagnostic
modality. This may introduce a selection bias. Perhaps
all of the benign lesions that have ‘‘classic’’ radio-
graphic appearances (e.g. serous cystadenomas or
pseudocysts) are being managed expectantly without
surgery. Even if this is the case, it does not change the
implications of this study, because the remaining
lesions cannot be differentiated.
Conclusions
Cystic lesions of the pancreas often impersonate one
another  cystic neoplasms as pancreatic pseudocysts,
peripancreatic cystic lesions as pancreatic cysts, ser-
ous adenomas as mucinous neoplasms, IPMN as
chronic pancreatitis. To some degree, they can be
differentiated by clinical presentation and the diag-
nostic modalities discussed above. The accuracy of
each of these diagnostic procedures is subject to errors
in technique of examination and interpretation. As L.
Henry Garland stated: ‘‘The former are correctable
with care, and the latter partly correctable with
training and experience’’ [12]. This series illustrates
the persistent diagnostic dilemma presented by cystic
pancreatic lesions. All symptomatic patients should
undergo resection. A large portion of even asympto-
matic lesions are premalignant or malignant. There-
fore, while asymptomatic lesions with the radiologic
appearance of serous cystadenomas may be followed
with serial imaging, any change in appearance should
prompt resection. Ultimately, the final recommenda-
tion must remain: in uncertain cases, err on the side of
resection.
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Appendix I. Morphologic features recorded for each CT and MR.
Imaging findings
Location
Size
Wall thickness
Loculation
No. of locules
Septal thickness
Average locule size
Largest locule size
Presence of solid nodules
Central scar
Calcification and location
Vascular encasement
Lesion communicated with pancreatic duct
(Predominantly) exophytic
MR signal intensity of cyst fluid (on T1)
Upstream pancreatic atrophy
Upstream pancreatic duct diameter
Biliary diameter
Evidence of acute pancreatitis
Pancreatic calcifications
Locoregional adenopathy
Hepatic or other metastases
Cystic pancreatic lesions 69
